21 related articles for article (PubMed ID: 1723315)
1. The Hematopoietic Bone Marrow Niche Ecosystem.
Fröbel J; Landspersky T; Percin G; Schreck C; Rahmig S; Ori A; Nowak D; Essers M; Waskow C; Oostendorp RAJ
Front Cell Dev Biol; 2021; 9():705410. PubMed ID: 34368155
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation.
Szyska M; Na IK
Front Immunol; 2016; 7():118. PubMed ID: 27066008
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation.
Xie M; Fu HX; Chang YJ; Xu LP; Liu DH; Zhang XH; Han W; Liu KY; Huang XJ
Int J Hematol; 2012 Jul; 96(1):109-21. PubMed ID: 22674381
[TBL] [Abstract][Full Text] [Related]
4. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions.
Kuznetsov SA; Mankani MH; Bianco P; Robey PG
Stem Cell Res; 2009 Jan; 2(1):83-94. PubMed ID: 19383412
[TBL] [Abstract][Full Text] [Related]
5. Hematologic aspects of myeloablative therapy and bone marrow transplantation.
Riley RS; Idowu M; Chesney A; Zhao S; McCarty J; Lamb LS; Ben-Ezra JM
J Clin Lab Anal; 2005; 19(2):47-79. PubMed ID: 15756708
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
8. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
9. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
11. Stromal fibroblastic and hematopoietic progenitors in patients with graft-versus-host disease (GVHD).
Okamoto T; Kanamaru A; Kakishita E; Nagai K
Int J Hematol; 1991 Aug; 54(4):299-306. PubMed ID: 1723315
[TBL] [Abstract][Full Text] [Related]
12. Concise review: the bone marrow niche as a target of graft versus host disease.
von Bonin M; Bornhäuser M
Stem Cells; 2014 Jun; 32(6):1420-8. PubMed ID: 24585665
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
